Anti-Xa monitoring of low-molecular-weight heparin in adult patients with cancer-Reference-Cited by-同舟云学术

Anti-Xa monitoring of low-molecular-weight heparin in adult patients with cancer

Published:2016-12-02 Issue:1 Volume:2016 Page:206-207
ISSN:1520-4391
Container-title:Hematology
language:en
Short-container-title:

Author:

Kreuziger Lisa Baumann¹,Streiff Michael²

Affiliation:

1. BloodCenter of Wisconsin, Division of Hematology and Oncology, Medical College of Wisconsin, Milwaukee, WI, and

2. Department of Medicine, Division of Hematology, Johns Hopkins University School of Medicine, Baltimore, MD

Abstract

Abstract A 68-year-old man developed a right femoral vein deep vein thrombosis and bilateral pulmonary embolism while receiving chemotherapy for stage IV prostate cancer. His creatinine at diagnosis is 1.4 mg/dL, with an estimated clearance of 63 mL/min. In patients with cancer, should low-molecular-weight heparin treatment be dosed according to weight, or adjusted using anti-Xa levels?

Publisher

American Society of Hematology

Subject

Hematology

Link

http://ashpublications.org/hematology/article-pdf/2016/1/206/1252544/hem088825.pdf

Reference15 articles.

1. Low-molecular-weight heparin versus a coumarin for the prevention of recurrent venous thromboembolism in patients with cancer;Lee;N Engl J Med,2003

2. Tinzaparin vs warfarin for treatment of acute venous thromboembolism in patients with active cancer: a randomized clinical trial;Lee;JAMA,2015

3. Recurrent venous thromboembolism and bleeding complications during anticoagulant treatment in patients with cancer and venous thrombosis;Prandoni;Blood,2002

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pulmonary Thrombosis despite Therapeutic Anticoagulation in COVID-19 Pneumonia: A Case Report and Literature Review;Viruses;2023-07-12

2. How to Choose An Appropriate Anticoagulant for Cancer-Associated Thrombosis;J NATL COMPR CANC NE;2021

3. Monitoring of anticoagulation in thrombotic antiphospholipid syndrome;Journal of Thrombosis and Haemostasis;2021-02-20

4. Monitoring anti-Xa levels in patients with cancer-associated venous thromboembolism treated with bemiparin;Clinical and Translational Oncology;2019-12-20

5. Update on Management of Portal Vein Thrombosis and the Role of Novel Anticoagulants;Journal of Clinical and Translational Hepatology;2019-06-28